CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in Europe
Retrieved on:
Monday, March 14, 2022
Sentinel, Clinic, RNA transfection, Toronto Stock Exchange, PCR, Company, Inflammation, Kevin, CLIA, Cell, Cancer, Saliva, Conditional sentence, Harley Street, COC, OTCQB, Deepening, Metabolism, Patient, Telehealth, Antibody testing, AVRT, Blood, Technology, Radiation, TSX, Population, COVID-19, CAP, Polymerase chain reaction, Program, Protocol, CEO, Oncology, Medical imaging, Pharmaceutical industry, Vaccine
This builds on the availability of the service and program in the UK, the US and Canada.
Key Points:
- This builds on the availability of the service and program in the UK, the US and Canada.
- The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage.
- Developed by scientists and oncologists, the COC Protocol is intended for adjunctive administration alongside standard-of-care cancer therapy.
- StageZero Life Sciences trades on the Toronto Stock exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.